S Aspley

Author PubWeight™ 12.80^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	The purification and properties of myo-inositol monophosphatase from bovine brain.	Biochem J	1988	1.80
2	The dephosphorylation of inositol 1,4-bisphosphate to inositol in liver and brain involves two distinct Li+-sensitive enzymes and proceeds via inositol 4-phosphate.	Biochem J	1988	1.49
3	Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine.	Int J Obes Relat Metab Disord	1998	1.10
4	Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors.	Br J Pharmacol	2004	1.04
5	[3H]quaternised ICS 205-930 labels 5-HT3 receptor binding sites in rat brain.	Eur J Pharmacol	1988	0.98
6	Central c-fos expression following 20kHz/ultrasound induced defence behaviour in the rat.	Brain Res Bull	1997	0.92
7	Effects of lesioning noradrenergic neurones in the locus coeruleus on conditioned and unconditioned aversive behaviour in the rat.	Prog Neuropsychopharmacol Biol Psychiatry	2001	0.82
8	Strain differences to the effects of aversive frequency ultrasound on behaviour and brain topography of c-fos expression in the rat.	Brain Res	2000	0.80
9	Additive effects on rat brain 5HT release of combining phentermine with dexfenfluramine.	Int J Obes Relat Metab Disord	2001	0.80
10	Pharmacological manipulation of ultrasound induced defence behaviour in the rat.	Psychopharmacology (Berl)	1996	0.79
11	Comparison of the effects of sibutramine and other weight-modifying drugs on extracellular dopamine in the nucleus accumbens of freely moving rats.	Synapse	2000	0.79
12	Scintigraphy can be used to compare delivery of sore throat formulations.	Int J Clin Pract	2009	0.77
13	Chronic, but not acute, dosing of antipsychotic drugs alters neurotensin binding in rat brain regions.	Br J Pharmacol	2000	0.75
14	A highly sensitive and selective radioimmunoassay for the measurement of neurotensin.	J Neurosci Methods	2000	0.75
15	Randomised, double-blind, placebo-controlled studies on flurbiprofen 8.75 mg lozenges in patients with/without group A or C streptococcal throat infection, with an assessment of clinicians' prediction of 'strep throat'.	Int J Clin Pract	2014	0.75